XM22

· Merckle GmbH

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for XM22, covering 2016-05-18 to 2016-05-18. Get the full timeline:

Most recent: Clinical Trial Update: PK/PD of XM22 in Children With Ewing Family of Tumors or Rhabdomyosarcoma [Phase 1]